# NUNZIA PHARMACEUTICAL Co

NUNZIA PHARMACEUTICAL Co is a company headquartered in Long Beach, CA, United States.

## Company overview

- **Legal name:** NUNZIA PHARMACEUTICAL Co
- **Former names in filing history:** Arizona Gold & Onyx Mining Co (2018-05-08 to 2020-01-03); VIKING CAPITAL GROUP INC (1997-11-20 to 2010-07-30)
- **Classification:** Company
- **Industry (SIC):** 2833 — Medicinal Chemicals & Botanical Products
- **Headquarters:** Long Beach, CA, United States
- **Incorporated in:** UT
- **Fiscal year end:** December 31
- **SEC CIK:** 0000886093

## About

NUNZIA PHARMACEUTICAL Co is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000886093, and its reported industry is Medicinal Chemicals & Botanical Products. In 10-K filed on 2022-04-15, it reported annual revenue of USD 0; net income of USD -78,062,770; total assets of USD 5,131 for the fiscal period ended 2021-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2021 (period ended 2021-12-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$78.1M (USD -78,062,770)
- **Total assets:** $5,131 (USD 5,131)
- **Cash and equivalents:** $131 (USD 131)
- **Operating cash flow:** -$86,776 (USD -86,776)

### FY2020 (period ended 2020-12-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$9.0M (USD -9,016,327)
- **Total assets:** $0 (USD 0)
- **Operating cash flow:** $0 (USD 0)
- **Later filings:** Net income, Operating cash flow: shown as originally filed; later filings report different values for the same periods.

### FY2018 (period ended 2018-12-31)

- **Net income:** -$18,576 (USD -18,576)
- **Total assets:** $0 (USD 0)

## Recent SEC filings

- Form 10-Q — filed 2022-11-14 — period 2022-09-30 — FORM 10-Q
- Form 10-Q — filed 2022-10-03 — period 2022-06-30 — 10-Q
- Form 10-Q — filed 2022-05-23 — period 2022-03-31 — QUARTERLY REPORT
- Form 10-K — filed 2022-04-15 — period 2021-12-31 — FORM 10-K
- Form 10-K/A — filed 2022-03-29 — period 2020-12-31 — FORM 10-K/A
- Form 8-K — filed 2022-03-18 — period 2022-03-17 — NUNZIA PHARMACEUTICAL COMPANY - FORM 8-K SEC FILING
- Form 8-K — filed 2022-03-02 — period 2022-03-01 — NUNZIA PHARMACEUTICAL COMPANY - FORM 8-K SEC FILING
- Form 10-Q — filed 2021-11-10 — period 2021-09-30 — NUNZIA PHARMACEUTICAL COMPANY - FORM 10-Q SEC FILING
- Form 10-Q — filed 2021-09-17 — period 2021-06-30 — NUNZIA PHARMACEUTICAL COMPANY - FORM 10-Q SEC FILING
- Form 10-Q — filed 2021-09-17 — period 2021-03-31 — NUNZIA PHARMACEUTICAL COMPANY - FORM 10-Q SEC FILING
- Form 10-K — filed 2021-09-16 — period 2020-12-31 — NUNZIA PHARMACEUTICAL COMPANY - FORM 10-K SEC FILING
- Form 10-Q — filed 2021-09-16 — period 2020-09-30 — NUNZIA PHARMACEUTICAL COMPANY - FORM 10-Q SEC FILING

---

Updated: 2026-10-23T20:12:17Z

Canonical page: https://altss.com/profile/nunzia-pharmaceutical-co

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology